Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/09/2859911/0/en/eFFECTOR-Therapeutics-to-Participate-in-Upcoming-Investor-Conference.html
https://endpts.com/effectors-lead-nsclc-program-falls-through-stock-crashes/
https://www.globenewswire.com/news-release/2024/03/25/2851978/0/en/eFFECTOR-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com//news-release/2024/02/05/2823517/0/en/eFFECTOR-Therapeutics-to-Present-at-Oppenheimer-34th-Annual-Healthcare-Life-Sciences-Conference.html
https://www.globenewswire.com/news-release/2024/01/29/2819427/0/en/eFFECTOR-Therapeutics-Announces-Closing-of-15-Million-Registered-Direct-Offering-Priced-At-The-Market-Under-Nasdaq-Rules.html
https://www.globenewswire.com//news-release/2024/01/25/2816695/0/en/eFFECTOR-Therapeutics-Announces-15-Million-Registered-Direct-Offering-Priced-At-The-Market-Under-Nasdaq-Rules.html
https://www.globenewswire.com//news-release/2024/01/09/2806253/0/en/eFFECTOR-Therapeutics-to-Host-Virtual-Investor-R-D-Day-on-January-24-2024.html
https://www.globenewswire.com//news-release/2024/01/09/2806241/0/en/eFFECTOR-Therapeutics-Announces-Reverse-Stock-Split.html
https://www.globenewswire.com//news-release/2023/12/08/2793183/0/en/eFFECTOR-Therapeutics-Announces-New-Positive-Interim-Data-from-Dose-Escalation-and-Phase-2-Expansion-Cohorts-of-Zotatifin-in-ER-Metastatic-Breast-Cancer-Patients.html
https://www.globenewswire.com//news-release/2023/11/28/2786889/0/en/eFFECTOR-Receives-U-S-FDA-Fast-Track-Designation-for-Zotatifin-in-Combination-with-Fulvestrant-and-Abemaciclib-for-Treatment-of-ER-HER2-Advanced-Metastatic-Breast-Cancer.html